Publicações

726Mo Outcomes by Histology and Prior Therapy with Lenvatinib plus Pembrolizumab Vs Treatment of Physician’s Choice in Patients with Advanced Endometrial Cancer (Study 309/Keynote-775)

AuthID
P-00V-T8J

Author(s)

Colombo, N

Lorusso, D

Herráez, AC

Santin, A

Colomba, E

Miller, D

Fujiwara, K

Pignata, S

Floquet, A

Monk, B

Banerjee, S

Penson, R

Kristeleit, R

Fabbro, M

Orlando, M

Mackay, H

Jensen, E

Dutta, L

Orlowski, R

Makker, V

Tipo de Documento

Article

Year published

2021

Publicado

in Annals of Oncology, ISSN: 0923-7534

Volume: 32, Páginas: S729-S730

Indexing

Crossref^®17

Google Scholar^®

Metadata
Fontes

Publication Identifiers

DOI: 10.1016/j.annonc.2021.08.1169

Source Identifiers

ISSN: 0923-7534

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

726Mo Outcomes by Histology and Prior Therapy with Lenvatinib plus Pembrolizumab Vs Treatment of Physician’s Choice in Patients with Advanced Endometrial Cancer (Study 309/Keynote-775)

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

726Mo Outcomes by Histology and Prior Therapy with Lenvatinib plus Pembrolizumab Vs Treatment of Physician’s Choice in Patients with Advanced Endometrial Cancer (Study 309/Keynote-775)

Links Úteis

Ajuda